Twist Bioscience officer proposes $1.91M share sale
The notice says the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Twist Bioscience Corp (TWST) is the issuer in a Rule 144 notice for officer Paula Green's proposed sale of 10,088 common shares, with aggregate market value $1,905,459.77. The approximate sale date is October 2, 2026; Fidelity Brokerage Services LLC is listed as broker and NASDAQ as the exchange. The shares are from restricted stock vesting dated October 1, 2026; the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution. Jared Cook signed as the broker's duly authorized representative and Paula Green's attorney-in-fact.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.